Literature DB >> 15793737

Are prophylactic antibiotics necessary with clean intermittent catheterization? A randomized controlled trial.

Simon A Clarke1, Madan Samuel, Su-Anna Boddy.   

Abstract

BACKGROUND/
PURPOSE: Clean intermittent catheterization has been an established practice for more than 3 decades. The validity of antibiotic prophylaxis has been questioned although not tested.
METHODS: Eighty-five patients were recruited into a randomized controlled trial. The randomization involved the placement into 1 of 2 groups: (A) continuing antibiotics or (B) discontinuing antibiotics. The trial would last 4 months with the outcome being a confirmed urinary tract infection. All groups were matched for age, sex, and pathology.
RESULTS: The incidence of urinary tract infections was significantly increased in the group who continued to use antibiotics (n = 20) when compared with the group who discontinued prophylaxis (n = 3). The common infecting organism was Escherichia coli.
CONCLUSIONS: The use of prophylactic antibiotics for children who intermittently catheterize may not be necessary. The use of prophylactic antibiotics may result in increased rates of infection because of the development of resistant organisms.

Entities:  

Mesh:

Year:  2005        PMID: 15793737     DOI: 10.1016/j.jpedsurg.2004.11.027

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  14 in total

Review 1.  Neuropathic bladders: Investigation and treatment through their lifetime.

Authors:  Peter D Metcalfe
Journal:  Can Urol Assoc J       Date:  2017 Jan-Feb       Impact factor: 1.862

2.  Urinary tract infections in children with spina bifida: an inventory of 41 European centers.

Authors:  Bas S H J Zegers; Pauline L H Winkler-Seinstra; Cuno S P M Uiterwaal; Tom V P M de Jong; Jan L L Kimpen; Catharine C E de Jong-de Vos van Steenwijk
Journal:  Pediatr Nephrol       Date:  2008-12-09       Impact factor: 3.714

3.  Prophylactic antibiotics to prevent urinary tract infection during clean intermittent self-catheterization (CISC) for management of voiding dysfunction after prolapse and incontinence surgery: a decision analysis.

Authors:  Gary Sutkin; Jerry L Lowder; Kenneth J Smith
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-04-10

Review 4.  Clean intermittent catheterization revisited.

Authors:  Eliza Lamin; Diane K Newman
Journal:  Int Urol Nephrol       Date:  2016-03-08       Impact factor: 2.370

Review 5.  Long-term, low-dose prophylaxis against urinary tract infections in young children.

Authors:  Per Brandström; Sverker Hansson
Journal:  Pediatr Nephrol       Date:  2014-06-07       Impact factor: 3.714

6.  Urinary tract infections in children with myelodysplasia in whom clean intermittent catheterization was administered.

Authors:  Zuhal Albayrak Yıldız; Cengiz Candan; Mustafa Arga; Pınar Turhan; Pınar İşgüven; Müferet Ergüven
Journal:  Turk Pediatri Ars       Date:  2014-03-01

Review 7.  [Neurogenic bladder function disorders in patients with meningomyelocele: S2k guidelines on diagnostics and therapy].

Authors:  R Stein; C Assion; R Beetz; M Bürst; R Cremer; A Ermert; M Goepel; E Kuwertz-Bröking; B Ludwikowski; T Michael; J Pannek; H Peters; D Rohrmann; I Rübben; A Schröder; R Trollmann; J W Thüroff; W Wagner
Journal:  Urologe A       Date:  2015-02       Impact factor: 0.639

Review 8.  WITHDRAWN: Intermittent catheterisation for long-term bladder management.

Authors:  Jacqui Prieto; Catherine L Murphy; Katherine N Moore; Mandy Fader
Journal:  Cochrane Database Syst Rev       Date:  2017-08-08

9.  Enhanced susceptibility to urinary tract infection in the spinal cord-injured host with neurogenic bladder.

Authors:  Zarine R Balsara; Sherry S Ross; Paul C Dolber; John S Wiener; Yuping Tang; Patrick C Seed
Journal:  Infect Immun       Date:  2013-06-10       Impact factor: 3.441

Review 10.  The urological management of children with spinal cord injury.

Authors:  Jairam R Eswara; Miguel Castellan; Ricardo González; Nicolas Mendieta; Marc Cendron
Journal:  World J Urol       Date:  2018-08-13       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.